MedTrace Logo

Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification

NCT00823121 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2010-01-20

No results posted yet for this study

Summary

Cryopreservation of all embryos and transferring them subsequently in assisted reproductive technology (ART) cycles to improve outcome.

Conditions

  • In Vitro Fertilization

Interventions

PROCEDURE

freezing embryos by vitrification

vitrification by Cryotop method

PROCEDURE

fresh embryo transfers

fresh embryo transfers

DRUG

buserelin

Daily administration of 500 µg subcutaneous buserelin from day 21 of menstrual cycle; reduce to 250 µg daily when ovarian suppression is confirmed.

DRUG

recombinant FSH

gonadotropin stimulation with rFSH 150 IU/day from day 2 of menstrual cycle

DRUG

human chorionic gonadotropin (pregnyl)

hCG 10,000 IU is administered when at least 2 follicles reach a mean diameter of 18 mm.

Sponsors & Collaborators

  • Yazd Research & Clinical Center for Infertility

    lead OTHER

Principal Investigators

  • abbas aflatoonian, M.D. · Research and Clinical Center for Infertility

  • homa oskouian, M.D. · Research and Clinical Center for Infertility

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-02-28
Completion
2009-12-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00823121 on ClinicalTrials.gov